Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,369,000 | 4,745,000 | 3,231,000 | 4,927,000 | 6,130,000 |
| Marketable Securities | 849,000 | 849,000 | 1,230,000 | 884,000 | 613,000 |
| Inventories | 3,193,000 | 2,890,000 | 3,035,000 | 2,334,000 | 2,143,000 |
| Other current assets | 5,287,000 | 7,107,000 | 5,654,000 | 5,117,000 | 7,121,000 |
| TOTAL | $15,563,000 | $15,591,000 | $13,150,000 | $13,262,000 | $16,007,000 |
| Non-Current Assets | |||||
| PPE Net | 8,335,000 | 7,421,000 | 7,615,000 | 6,848,000 | 6,413,000 |
| Intangibles | 32,501,000 | 33,666,000 | 38,013,000 | 39,244,000 | 34,514,000 |
| Other Non-Current Assets | 4,978,000 | 3,973,000 | 4,576,000 | 3,172,000 | 3,190,000 |
| TOTAL | $45,814,000 | $45,060,000 | $50,204,000 | $49,264,000 | $44,117,000 |
| Total Assets | $61,377,000 | $60,651,000 | $63,354,000 | $62,526,000 | $60,124,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,822,000 | 1,754,000 | 2,242,000 | 2,220,000 | 849,000 |
| Accounts payable and accrued liabilities | 1,774,000 | 1,720,000 | 3,611,000 | 2,990,000 | 3,469,000 |
| TOTAL | $18,117,000 | $16,292,000 | $16,383,000 | $15,256,000 | $14,869,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,730,000 | 17,359,000 | 15,560,000 | 14,495,000 | 14,109,000 |
| Other Non-Current Liabilities | 8,438,000 | 8,016,000 | 9,092,000 | 10,329,000 | 9,857,000 |
| TOTAL | $28,664,000 | $30,315,000 | $30,329,000 | $30,601,000 | $26,746,000 |
| Total Liabilities | $46,781,000 | $46,607,000 | $46,712,000 | $45,857,000 | $41,615,000 |
| Shareholders' Equity | |||||
| Common Shares | 328,000 | 317,000 | 317,000 | 316,000 | 316,000 |
| Retained earnings | 2,812,000 | 5,683,000 | 8,221,000 | 8,140,000 | 11,834,000 |
| Other shareholders' equity | 1,893,000 | 1,888,000 | 1,876,000 | 1,894,000 | 1,883,000 |
| TOTAL | $13,127,000 | $12,468,000 | $14,960,000 | $14,854,000 | $18,490,000 |
| Total Liabilities And Equity | $59,908,000 | $59,075,000 | $61,672,000 | $60,711,000 | $60,105,000 |